Dimethylamine

Dimethylamine

SCHEMBL745789

CCCCCCCCCCCCCC(=O)C(C)(C)C(=O)CCCCCCCCCCCCC.CNC

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 8/20 0.57
▸ CES1 P23141 8/20 0.57
▸ CES2 O00748 5/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ HSP90AA1 P07900 1/20 0.48
▸ PPARG P37231 4/20 0.48
▸ PPARD Q03181 4/20 0.48
▸ PPARA Q07869 4/20 0.48
▸ TSHR P16473 3/20 0.48
▸ GPR84 Q9NQS5 3/20 0.48
▸ HDAC11 Q96DB2 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ SLC22A6 Q4U2R8 1/20 0.48
▸ SLC22A8 Q8TCC7 1/20 0.48
▸ TLR2 O60603 1/20 0.48
▸ ESR1 P03372 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL3246194 0.87 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
Trimethylammonium SCHEMBL4658910 0.87 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
Trimethylammonium SCHEMBL1711942 0.87 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
Dimethylamine SCHEMBL12980876 0.83 FAAH (0.53) FAAHCES1CES2MEN1KMT2A
Dimethylamine SCHEMBL5538214 0.83 FAAH (0.53) FAAHCES1CES2MEN1KMT2A
SCHEMBL12749827 0.83 FAAH (0.53) FAAHCES1CES2MEN1KMT2A
SCHEMBL29069456 0.83 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
SCHEMBL22033669 0.83 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
SCHEMBL22033577 0.83 FAAH (0.57) FAAHCES1CES2MEN1KMT2A
SCHEMBL12749833 0.83 FAAH (0.57) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012167144-A1 NANOCOATINGS FOR BIOLOGICAL MATERIALS PAXVAX, INC. (US) 2012-12-06 — — WO claimed
EP-2430168-A1 COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND COLIPIDS FOR DELIVERING THERAPEUTICS MOLECULES Cui, Kunyuan (US) 2012-03-21 — — EP disclosed
WO-2011084721-A2 CATIONIC MOLECULE AND METHOD OF USE AGAVE PHARMA INC (US) 2011-07-14 — — WO disclosed
WO-2010135207-A1 COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND COLIPIDS FOR DELIVERING THERAPEUTICS MOLECULES AGAVE PHARMA, INCORPORATED (US) 2010-11-25 — — WO disclosed
Send feedback